MUSIC-HD-Pilot Study Evaluating the Benefits of Music Therapy Combined With Conventional Treatment on Irritability and Impulsivity in Patients With Huntington's Disease
Recruiting
This trial will evaluate whether music therapy combined with conventional management reduces irritability and impulsivity in patients with early-stage Huntington’s disease. This pilot study aims to show the interest of alternative non-pharmacological(not using drugs) measures such as a digital music therapy tool, adapted to an audience of Huntington’s patients, to help manage the psychobehavioral symptoms frequently observed in this affection, and to avoid breakdowns due to caregiver exhaustion.
The participants will be recruited at the Clinical Investigation Center (CIC) of the University Hospital of Poitiers and will receive music therapy for 3 months.
After the start of the musical intervention, 3 visits (at 1 month, 3 months and 6 months) will be performed by practitioners, nurses and neuropsychologist at the CIC. Participants will answer questionnaires : irritability (BITe and PBA-s sub-score), impulsivity (UPPS-P and Delay discounting task), anxiety (STAI-Y and HAM-A), and quality of life: H-QoL-I. Caregivers will be asked to rate the patient’s irritability and anxiety using a Lickert scale from 0 to 10, and the patient’s impulsivity with the ISDC.
This an open label.
Phase: not applicable
Subtype: Interventional Therapeutic
Primary Purpose: Supportive Care
Intervention Type: behavourial
Primary Intervention: music
Duration: 3 months
Ages Eligible
for Study:
18 Years and older
Sexes Eligible
for Study:
All
Accepts Healthy Volunteers:
No
- Age >= 18 years
- Huntington disease genetically confirmed by the presence of at least 35 repeats of the CAG triplet in exon 1 of the HTT gene
- UHDRS (Unified Huntington’s disease Rating Scale) score <= 5 with a diagnostic confidence score =4
- Absence of significant cognitive impairment MoCA >=24
- Stable drug therapy in the 28 days prior inclusion and during the study
- Without legal tutors or subordination
- Affiliated to a health insurance system as required by the French law on biomedical research
- Written informed consent for participation in the study
- Inability to give free and informed consent for study participation
- Significant hearing impairment
- Participating to another study the day of enrollement
- Persons benefiting from enhanced protection, i.e.persons deprived of their liberty by a judicial or administrative decision, adults under legal and finally patients in a vital emergency situation.
LOCATIONS
COUNTRIES
France
TRIAL SITE: CHU POITERS/CIC
Poitiers, France
Name: Isabelle BENATRU, Dr
Tel: 05 49 44 33 89 ext +33
Email: isabelle.benatru@chu-poitiers.fr
